Navigation Links
Accentia Biopharmaceuticals Scientific Presentations Demonstrate,Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at,the Annual Meeting of the American Academy of Allergy, Asthma, and,Immunology

B: BVTI), is currently in a Fast-Tracked Phase 3 clinical trial. The Company is also proposing to enter Phase 3 clinical trials for Multiple Sclerosis using Revimmune(TM), which uses an approved drug in an exclusively licensed method of therapy to "reboot" a patient's immune system. Revimmune was developed at the Johns Hopkins School of Medicine for the elimination of autoimmunity, and Accentia has acquired the exclusive worldwide rights for all autoimmune diseases. For further information, please visit www.accentia.net.

Forward-Looking Statements

Statements in this release that are not strictly historical in nature constitute "forward-looking statements." Such statements include, but are not limited to, statements about SinuNase, BiovaxID, AutovaxID, Revimmune and any other statements relating to products, product candidates, product development programs the FDA or clinical trial process including the commencement, process or completion of clinical trials or the regulatory process. Such statements may include, without limitation, statements with respect to the Company's plans, objectives, expectations and intentions and other statements identified by words such as "may," "could," "would," "should," "believes," "expects," "anticipates," "estimates," "intends," "plans" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results of Accentia to be materially different from historical results or from any results expressed or implied by such forward-looking statements. These factors include, but are not limited to, risks and uncertainties related to the progress, timing, cost, and results of clinical trials and product development programs; difficulties or delays in obtaining regulatory approval for product candidates; competition from other pharmaceutical or biotechnology companies; and the additional risks discussed in filings with the Securities and Exchange C
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
2. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
3. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
4. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois
5. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
6. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
7. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
8. MEDIA ADVISORY: Subsets of Landmark Diabetes Trials Investigating MacroVascular Outcomes Presented at the American Diabetes Association 67th Scientific Sessions
9. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
10. Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
11. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
Post Your Comments:
(Date:3/31/2015)... , Mar. 30, 2015 Research and Markets ... addition of the "Eurpoean Automatic External Defibrillators ... (Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, ... their offering. The European automated external ... a CAGR of 10.9% from 2014 to 2019 ...
(Date:3/31/2015)... March 31, 2015 According ... and Chemical Instrumentation Market (Chromatography, Electrophoresis, DNA Sequencer, PCR, ... Incubator, Fume Hood, Centrifuge) - Global Forecast to ... and Chemical Instrumentation Market is expected to reach ... from 2014 to 2019. Browse ...
(Date:3/31/2015)... 2015  Mark Farrah Associates (MFA), www.markfarrah.com ... plans in their recent analysis brief.  According to ... in Medicare Advantage plans as of March 2015, ... year-over-year.  54.3 million people are eligible for Medicare, ... Services (CMS), with an unpenetrated market of 37 ...
Breaking Medicine Technology:Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 2Eurpoean Automatic External Defibrillators (Semi-Automated, Fully-Automated) Market 2015-2019 - Pre-Hospitals, Public Access Market, Hospitals, Alternate Care Market, Home Analysis 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 2Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 3Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 4Life Science and Chemical Instrumentation Market Worth $48.84 Billion by 2019 5Medicare Advantage Enrollment Reaches 17 Million According to Mark Farrah Associates 2
... 100% with ... Masimo,s PI measurement, IRVINE, Calif., Nov. 14 ... and Low,Perfusion pulse oximetry, reported that a new independent and objective,clinical ... detection of congenital heart defects (CHD) in newborns with,duct-dependent systemic circulation. ...
... Current Research Findings on the ... Treatment of Localized Prostate Cancer, TORONTO, Nov. 14 ... the Sonablate(R) 500 - a Health Canada,approved treatment for localized ... AstraZeneca Canada Inc, Can-Am HIFU, a prostate,cancer treatment centre, will ...
Cached Medicine Technology:New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns 2New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns 3New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns 4Prostate Cancer Treatment Centre Receives Funding for Clinical Trials 2
(Date:3/31/2015)... 31, 2015 BESLER Consulting today ... “The Value of an Independent Cost Report Review.” ... a critical role in the determination of Medicare ... appropriate understanding and review, this report can assist ... planning. , This white paper discusses:, ...
(Date:3/31/2015)... 31, 2015 With intravenous (IV) infusion ... a catheter. Patients, typically, are prescribed IV infusion therapy ... medications are no longer effective. Illness often leads ... help with electrolyte imbalances. Infusion therapy benefits the ... addition to treating dehydration, IV infusion therapy can be ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Williams ... a repair visit when their home comfort is ... and make the visit fit into the customer’s ... provide fast, quality repair at requested times. ... and commercial customers in the Indianapolis area can ...
(Date:3/31/2015)... 31, 2015 DataEntryOutsourced is ... of data entry experts to handle the specialized requirements ... managing a complex nutritional scoring system for a wide ... trial of their nutrition scale data entry services. ... Case Study on U.S. Food Nutrition Scale Data Entry." ...
(Date:3/31/2015)... The status of more than 1,000 Mirena ... Management Conference scheduled to be held in the U.S. ... 21st. According to court documents, the jurisdiction is currently ... lawsuits filed on behalf of women who allegedly suffered ... to the birth control device. (In re: Mirena IUD ...
Breaking Medicine News(10 mins):Health News:Intravenous Infusion Therapy Now Available at Urgent Care of Texas Centers; Hospital-Level Care in an Outpatient Setting. 2Health News:Williams Comfort Air Launches Online Scheduling Tool to Indianapolis-Area Home and Business Owners 2Health News:DEO Announces a Team of Dedicated Data Entry Operators for Nutrition Score Data Entry 2Health News:Mirena IUD Lawsuits Move Forward as Federal Court Readies to Convene Next Case Management Conference 2Health News:Mirena IUD Lawsuits Move Forward as Federal Court Readies to Convene Next Case Management Conference 3
... , , , NORCROSS, Ga., July 23 ... automated instrument-reagent systems to the blood transfusion industry, today reported financial results for ... , Fourth Quarter Financial Highlights , , ... $79.0 million, up 15% from $68.6 million in the same period last year. ...
... SACRAMENTO, Calif., July 23 Oscar Wright, chief executive officer of ... the Psycho Donuts shop, participated in an interview and debate Wednesday on ... , Oscar Wright released this statement today: ... administrator of the U.S. Small Business Administration, I appreciate an individual,s goal ...
... , , , , ... "Reform" Jeopardize Viability of Already-Troubled Texas Medicaid Program; ... , AUSTIN, Texas, July 23 /PRNewswire-USNewswire/ ... to Medicare-financed nursing home care as part of ongoing health reform negotiations ...
... , TROY, Mich., July 23 ... system, many of the country,s citizens are struggling to afford the ... of Americans have taken dangerous measures that can harm their health ... half, failing to fill a prescription or sharing a prescription. ...
... , , Tour Includes Demonstration ... CLEVELAND, July 23 Today, ... its model of healthcare, how it utilizes health information technology, and a ... of how the Clinic provides patients with cost-effective, high-quality clinical results. , ...
... , , , ... NEW YORK, July 23 National Minority Donor Awareness Day is August 1, ... Hudson Valley, Brooklyn/Staten Island, and New Jersey call on the community to help ... , Historically, National Minority Donor Awareness Day emphasized ...
Cached Medicine News:Health News:Immucor Announces Fiscal Fourth Quarter Results 2Health News:Immucor Announces Fiscal Fourth Quarter Results 3Health News:Immucor Announces Fiscal Fourth Quarter Results 4Health News:Immucor Announces Fiscal Fourth Quarter Results 5Health News:Immucor Announces Fiscal Fourth Quarter Results 6Health News:Immucor Announces Fiscal Fourth Quarter Results 7Health News:Immucor Announces Fiscal Fourth Quarter Results 8Health News:Immucor Announces Fiscal Fourth Quarter Results 9Health News:Immucor Announces Fiscal Fourth Quarter Results 10Health News:Mental Health Advocates Call for Psycho Donuts to Do the Right Thing 2Health News:Expressing Growing Concern, THCA Urges Texas Congressional Delegation to Protect Seniors' Medicare-Funded Nursing Home Care as Health Reform Debate Proceeds 2Health News:As the Government Continues to Work Toward Health Care Reform, Medtipster is Providing a Free Solution to Rising Health Care Costs for Americans Right Now 2Health News:President Obama's Visit to Cleveland Clinic Provides Look at High-Quality, Cost-Effective Healthcare Delivery Model 2Health News:President Obama's Visit to Cleveland Clinic Provides Look at High-Quality, Cost-Effective Healthcare Delivery Model 3Health News:The Gift of Life Flows Through Your Veins! 2Health News:The Gift of Life Flows Through Your Veins! 3
... is the ultimate research stereo microscope ... distance, wide zoom range, excellent image ... by a modular system of mechanical ... great flexibility, allowing adaptation to meet ...
... Nikon Instruments Inc., a world leader ... the introduction of its new Universal ... Nikon Eclipse upright microscope models, including ... This Universal Epi Illuminator provides ...
... color camera, delivers high-resolution images with outstanding detail ... The Q-Color3 is easy to set up and ... CCD - 1/1.8" Color ... bit digitization and preview options ...
... megapixel monochrome microscopy camera suitable for bright-field ... microscopy camera designed to capture publication quality ... resolution and can provide 5 frames per ... For preview, the resolution can be decimated ...
Medicine Products: